Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02669173
What this trial is testing

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT03294486
What this trial is testing

Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients

Who this might be right for
GlioblastomaBrain Cancer
Assistance Publique - Hôpitaux de Paris 78
Testing effectiveness (Phase 2)Looking for participantsNCT02977780
What this trial is testing

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Who this might be right for
Glioblastoma
David Reardon, MD 460
Not applicableStudy completedNCT07499141
What this trial is testing

Use of Fluorescence in Gliomas

Who this might be right for
High Grade GliomaGlioblastomaBrain Neoplasms
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria 41
Very early researchActive Not RecruitingNCT07585851
What this trial is testing

Administration of Repurposed Ketoconazole in Glioma Patients

Who this might be right for
Diffuse GliomaDiffuse Glioma, Grade IDiffuse Glioma, Grade II+2 more
Universitas Padjadjaran 80
Not applicableStudy completedNCT00400322
What this trial is testing

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Who this might be right for
Glioblastoma MultiformeCytomegalovirus Infection
Karolinska Institutet 42
Not applicableLooking for participantsNCT00083512
What this trial is testing

Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 200
Very early researchActive Not RecruitingNCT05182905
What this trial is testing

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Who this might be right for
GlioblastomaGliomaGlioblastoma Multiforme+1 more
Nader Sanai 97
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Early research (Phase 1)Study completedNCT02197169
What this trial is testing

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

Who this might be right for
Glioblastoma or Gliosarcoma
DNAtrix, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT02474966
What this trial is testing

Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study

Who this might be right for
Glioblastoma Multiforme of Brain
University of Roma La Sapienza 15
Testing effectiveness (Phase 2)UnknownNCT04077866
What this trial is testing

B7-H3 CAR-T for Recurrent or Refractory Glioblastoma

Who this might be right for
Recurrent GlioblastomaRefractory Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Testing effectiveness (Phase 2)Looking for participantsNCT06835803
What this trial is testing

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

Who this might be right for
Glioblastoma (GBM)
Brigham and Women's Hospital 56
Not applicableAvailableNCT02146066
What this trial is testing

Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Who this might be right for
GBMGlioblastoma Multiforme
Northwest Biotherapeutics
Testing effectiveness (Phase 2)Ended earlyNCT06359379
What this trial is testing

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

Who this might be right for
Glioblastoma, IDH-wildtype
Shuttle Pharmaceuticals, Inc. 30
Not applicableUnknownNCT01317888
What this trial is testing

Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAstrocytoma Anaplastic Foci
Drexel University 11
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT05718466
What this trial is testing

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

Who this might be right for
Recurrent or Progressive Glioblastoma
Henry Ford Health System 35
Next Page